A detailed history of Abel Hall, LLC transactions in Sanofi stock. As of the latest transaction made, Abel Hall, LLC holds 10,796 shares of SNY stock, worth $521,338. This represents 0.41% of its overall portfolio holdings.

Number of Shares
10,796
Previous 10,262 5.2%
Holding current value
$521,338
Previous $498 Million 24.96%
% of portfolio
0.41%
Previous 0.35%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$48.54 - $58.53 $25,920 - $31,255
534 Added 5.2%
10,796 $622 Million
Q2 2024

Jul 25, 2024

SELL
$45.39 - $50.36 $14,479 - $16,064
-319 Reduced 3.01%
10,262 $498 Million
Q1 2024

May 08, 2024

SELL
$45.75 - $52.48 $16,058 - $18,420
-351 Reduced 3.21%
10,581 $514 Million
Q4 2023

Feb 28, 2024

BUY
$43.13 - $54.79 $471,497 - $598,964
10,932 New
10,932 $544 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Abel Hall, LLC Portfolio

Follow Abel Hall, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abel Hall, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abel Hall, LLC with notifications on news.